Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention

Circulation: Cardiovascular Interventions

Volumn 5, Issue 2, 2012, Pages 227-236

  Yeh, Robert W ^a   Rosenfield, Kenneth ^a   Zelevinsky, Katya ^b   Mauri, Laura ^c   Sakhuja, Rahul ^d   Shivapour, Daniel M ^a   Lovett, Ann ^b   Weiner, Bonnie H ^e   Jacobs, Alice K ^f   Normand, Sharon Lise T ^b,g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Wellmont CVA Heart Institute   (United States)

^e SAINT VINCENT HOSPITAL   (United States)

^f BOSTON MEDICAL CENTER   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Outcomes research; Percutaneous coronary intervention; Performance measures

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BODY MASS; CARDIOGENIC SHOCK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INSURANCE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RACE; RESPIRATORY TRACT DISEASE; SMOKING; UNITED STATES;

AGED; ANGIOPLASTY; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT READMISSION; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; QUALITY OF HEALTH CARE; RISK; TIME FACTORS; UNITED STATES;

EID: 84860816394     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.967638     Document Type: Article

References (24)

1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360:1418-1428.
2. Krumholz HM, Merrill AR, Schone EM, Schreiner GC, Chen J, Bradley EH, Wang Y, Lin Z, Straube BM, Rapp MT, Normand SL, Drye EE. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407-413.
3. Wu AH, Harrison A, Maisel AS. Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testing. Eur J Heart Fail. 2004;6:309-312. (Pubitemid 38253050)
4. Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, Masica AL. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009; 4:211-218.
5. Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, Normand SL, Schreiner G, Spertus JA, Vidan MT, Wang Y, Krumholz HM. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010;3:97-103.
6. Medicare Payment Advisory Commission (US). Report to the Congress: promoting greater efficiency in Medicare. Washington, DC: MedPAC; 2007.
7. United States., United States. Congress. House. Office of the Legislative Counsel, United States. Congress. House. Committee on Ways and Means., United States. Congress. House. Committee on Energy and Commerce., United States. Congress. House. Committee on Education and Labor. Compilation of Patient Protection and Affordable Care Act: as amended through November 1, 2010 including Patient Protection and Affordable Care Act health-related portions of the Health Care and Education Reconciliation Act of 2010. Washington: US Government Printing Office; accessed October 1, 2011.
8. National Quality Forum Press Release. NQF endorses patient outcome measures for high-impact conditions. 2010. http://www.qualityforum.org/News-And- Resources/Press-Releases/2010/NQF-Endorses-Patient-Outcome-Measures-for-High- Impact-Conditions.aspx. Accessed October 5, 2011.
9. Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol. 2009;54:903-907.
10. Shahian DM, Silverstein T, Lovett AF, Wolf RE, Normand SL. Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation. 2007;115: 1518-1527. (Pubitemid 46648636)
11. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand SL. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med. 2008;359:1330-1342.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
13. Krumholz HM, Brindis RG, Brush JE, Cohen DJ, Epstein AJ, Furie K, Howard G, Peterson ED, Rathore SS, Smith SC Jr, Spertus JA, Wang Y, Normand SL. Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council: endorsed by the American College of Cardiology Foundation Circulation. 2006;113:456-462. (Pubitemid 43803208)
14. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20:512-522.
15. Yeh RW, Chandra M, McCulloch CE, Go AS. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med. 2011;9:78.
16. Krumholz HM, Wang Y, Mattera JA, Han LF, Ingber MJ, Roman S, Normand SL. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation. 2006;113:1683-1692.
17. Shahian DM, Wolf RE, Iezzoni LI, Kirle L, Normand SL. Variability in the measurement of hospital-wide mortality rates. N Engl J Med. 2011; 363:2530-2539.
18. Massachusetts Data Analysis Committee. Adult Percutaneous Coronary Intervention in the Commonwealth of Massachusetts, Fiscal Year 2009, October 1, 2008 to September 30, 2009. http://www.massdac.org/reports/pci.html. Accessed October 6, 2011.
19. National Quality Forum. National Voluntary Consensus Standards for Patient Outcomes: Measure Summary, Measure OT1-008-09. http://www.qualityforum. org/Projects/n-r/Patient-Outcomes/OT1-008- 09-Supplement,aspx. Accessed November 10, 2010.
20. Lindenauer PK, Bernheim SM, Grady JN, Lin Z, Wang Y, Merrill AR, Han LF, Rapp MT, Drye EE, Normand SL, Krumholz HM. The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for Medicare beneficiaries with pneumonia. J Hosp Med. 2010;5:E12-E18.
21. Hannan EL, Zhong Y, Krumholz H, Walford G, Holmes DR Jr, Stamato NJ, Jacobs AK, Venditti FJ, Sharma S, King SB III. 30-day readmission for patients undergoing percutaneous coronary interventions in New York State. J Am Coll Cardiol Cardiovasc Interv. 2011;4:1335-1342.
22. Khawaja FJ, Shah ND, Lennon RJ, Slusser JP, Alkatib AA, Rihal CS, Gersh BJ, Montori VM, Holmes DR, Bell MR, Curtis JP, Krumholz HM, Ting HH. Factors associated with 30-day readmission rates after percutaneous coronary intervention. Arch Intern Med. 2012;172:112-117.
23. Friedman B, Encinosa W, Jiang HJ, Mutter R. Do patient safety events increase readmissions? Med Care. 2009;47:583-590.
24. Joynt KE, Jha AK. Who has higher readmission rates for heart failure, and why? implications for efforts to improve care using financial incentives. Circ Cardiovasc Qual Outcomes. 2010;4:53-59.